医学分子生物学杂志 ›› 2024, Vol. 21 ›› Issue (5): 413-418.doi: 10.3870/j.issn.1672-8009.2024.05.004

• 论著 • 上一篇    下一篇

积雪草苷抑制伊马替尼耐药的 K562 细胞的生长和迁移 #br#

  

  1. 内蒙古医科大学附属医院输血科 呼和浩特市, 010050
  • 出版日期:2024-09-30 发布日期:2024-10-25
  • 基金资助:
    内蒙古自治区自然科学基金(No. 2022WZ01)

Asiaticoside Inhibits Cell Growth and Invasion of Imatinib-resistant K562 Cells #br#

  1. Department of Blood Transfusion, Inner Mongolia Medical University Affiliated Hospital, Hohhot, 010050, China
  • Online:2024-09-30 Published:2024-10-25

摘要: 目的 研究积雪草苷对慢性粒细胞白血病 ( chronic myelogenous leukemia, CML) 细胞增殖迁移和周期停滞的作用, 并且探讨了其对 GATA-1 表达的调节方法 CML 细胞系 K562、 抗伊马替尼(imatinib, IM) K562 细胞 (K562r) 和人源 CML 细胞为模型, CCK-8 测定不同浓度积雪草苷对 3 种细胞活力的影响选择 0、 25、 50、 100 μmol / L 积雪草苷处理 K562r 细胞, CFSE 标记测定细胞增殖, Transwell 测定细胞迁移, 流式细胞仪检测细胞周期, 蛋白质印迹检测 cyclin A、 CDK2、 CDK4、 cyclin D1、 Ki67、 PCNA、 VEGF、 MMP-9 MMP-14 蛋白水平结果 与对照组比较, 积雪草苷处理可显著抑制 K562r 细胞增殖和迁移, 并促进其细胞周期阻滞同时我们发现积雪草苷处理可显著上调 K562r 细胞中 GATA-1 水平结论 积雪草苷能够抑制 K562r 细胞增殖迁移并诱导其细胞周期阻滞, 其机制可能与 GATA-1 的表达上调相关

关键词: 积雪草苷, 慢性粒细胞白血病, 伊马替尼, 迁移, GATA-1

Abstract: Objective To study the effect of asiaticoside on the proliferation, invasion and cellcycle arrest of chronic myelogenous leukemia (CML) cells, and to explore its regulation on GATA-1 expression. Methods CML cell line K562, imatinib (IM) -resistant K562 cells (K562r) andhuman original CML cells were used for experiments. Cell viability was determined by CCK-8 assay. K562r cells were treated with 0, 25, 50, 100 μmol / L asiaticoside, then cell proliferation wasdetermined by colony formation assay, cell migration was determined by transwell assay, the cell cycle was measured by flow cytometry, the expression levels of cyclin A, CDK2, CDK4, cyclinD1, Ki67, PCNA, VEGF, MMP-9 and MMP-14 were detected by Western blotting. Results Compared with the control group, asiaticoside treatment significantly reduced the number of K562rcell colonies and migration cells, and induced the cell cycle arrest. In addition, the expression levelof GATA-1 in K562r cells was significantly up-regulated after asiaticoside treatment. Conclusion Asiaticoside can inhibit the proliferation and migration of K562r cells and induce cell cycle arrest,and the mechanism may be related to the up-regulation of GATA-1 expression.

Key words: asiaticoside, chronic myelogenous leukemia, imatinib, cell migration, GATA-1

中图分类号: